Trial intelligence / Profile preview

Intraoperative photodynamic diagnosis using 5-ALA in breast cancer surgery

jRCTs041220090Completed

Start
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of 5-aminolevulinic acid in breast cancer. Primary endpoints: Diagnostic odds ratio (usefulness) and Safety events related to study drug. Started Jan 2023; status: completed.

02

Drugs

5-aminolevulinic acid
03

Conditions

breast cancer

Beyond the preview

Go deeper on jRCTs041220090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041220090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call